KaplanMeier survival plot illustrating the differences in progression-free survival (PFS) between patients predicted to have metastasis (predicted PFS:1) and those predicted to be metastasis-free (predicted PFS:0) in the TCGA prostate adenocarcinoma cohort (n = 439). The x-axis represents survival time in months. The observed difference in survival is statistically significant with a p-value of <0.0001, assessed using the log-rank test.
